Mr. Bryan Baldasare - 17 May 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Brenda Edwards, attorney-in-fact for Mr. Bryan Baldasare
Issuer symbol
INM
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 16:24:33 UTC
Previous filing
19 May 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 -14,000 -50% $0.000000 14,000 17 May 2022 Common Shares 14,000 $0.8000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on May 17, 2022 and will vest monthly, in arrears, as follows: (i) 390 stock options will vest on the 17th day of each month for 35 months, and (ii) 350 stock options will vest on May 17, 2025 (the three year anniversary of Grant date).